24 results on '"F. Sorge"'
Search Results
2. Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study
- Author
-
Florence Missud, Berengere Koehl, F. Sorge, Valentine Brousse, Camille Aupiais, Laurent Holvoet, Assa Niakate, Nelly Schinckel, Marie-Hélène Odièvre, Pierre Mornand, Malika Benkerrou, Ghislaine Ithier, Albert Faye, Hôpital Robert Debré, Biologie Intégrée du Globule Rouge (BIGR (UMR_S_1134 / U1134)), Institut National de la Transfusion Sanguine [Paris] (INTS)-Université de La Réunion (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Université des Antilles (UA)-Université Paris Cité (UPCité), Epidémiologie Clinique et Evaluation Economique Appliquées aux Populations Vulnérables (ECEVE (U1123 / UMR_S_1123)), Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Cité (UPCité), Hôpital Jean Verdier [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), HAL-SU, Gestionnaire, Institut National de la Transfusion Sanguine [Paris] (INTS)-Université de La Réunion (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Université des Antilles (UA)-Université de Paris (UP), and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université de Paris (UP)
- Subjects
Male ,paediatric ,Adolescent ,030231 tropical medicine ,Yellow fever vaccine ,Anemia, Sickle Cell ,immunization ,03 medical and health sciences ,0302 clinical medicine ,Yellow Fever ,haemoglobinopathy ,medicine ,Humans ,Hydroxyurea ,Prospective Studies ,030212 general & internal medicine ,Child ,Adverse effect ,travel ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,biology ,business.industry ,Immunogenicity ,Vaccination ,Yellow Fever Vaccine ,hydroxycarbamide ,Antibody titer ,General Medicine ,medicine.disease ,Sickle cell anemia ,Immunity, Humoral ,3. Good health ,side effects ,Immunization ,Child, Preschool ,Africa ,Immunology ,biology.protein ,Female ,Antibody ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,medicine.drug - Abstract
Background Sickle cell disease (SCD) children are frequent travellers to countries where yellow fever (YF) is endemic, but there are no data regarding the safety and immunogenicity of the vaccine in such children treated with hydroxyurea (HU). The main objective of this study was to compare the tolerance and immune response to YF vaccination in SCD children treated or not with HU. Method SCD children Results Among the 52 SCD children vaccinated against YF, 17 (33%) were treated with HU. Only mild adverse events, mainly fever and local reaction, were observed in the HU group with a similar frequency in the non-HU group (57 and 35%, respectively, P = 0.30). YF antibody titres were measured in 15/17 patients in the HU group and 23/35 patients in the non-HU group after a median of 6.0 months (3.5–8.5) following vaccination. The geometric mean of YF antibody titre was similar in both groups. A protective antibody level was observed in 85% of the children in the HU group vs 100% in the non-HU group (P = 0.14), suggesting a lower effectiveness of the vaccine in patients on HU similarly to what has been described in patients on immune suppressive therapy for other vaccines. Conclusion YF vaccination seems to be safe and efficient in SCD children treated with HU. Considering the potential risk of severe complications in cases of YF while travelling in Africa for those patients, the benefit-to-risk ratio argues for YF vaccination in all SCD children. Control of a protective antibody titre may also be useful to ascertain an adequate response in those treated with HU.
- Published
- 2021
- Full Text
- View/download PDF
3. Fièvre au retour de voyage chez l’enfant
- Author
-
A. Faye, N. Velayudhan-Deschamps, J. Naudin, F Sorge, and R. Blondé
- Subjects
Risk ,medicine.medical_specialty ,Fever ,030231 tropical medicine ,Physical examination ,Infections ,Article ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,Epidemiology ,medicine ,Humans ,Child ,Travel ,medicine.diagnostic_test ,business.industry ,Optimal treatment ,Public health ,Tropical disease ,medicine.disease ,Checklist ,Family medicine ,Pediatrics, Perinatology and Child Health ,Etiology ,business ,Malaria ,Algorithms - Abstract
Résumé Les enfants voyageurs sont des millions dans le monde et sont exposés à de nombreux risques, infectieux ou non, dont les praticiens n’ont pas toujours l’expérience. La consultation d’un enfant fébrile après un voyage est de plus en plus fréquente. Ainsi, la notion d’antécédent de voyage doit être recherchée devant tout enfant fébrile. La démarche diagnostique prend en compte prioritairement des pathologies intertropicales potentiellement graves, comme le paludisme, qui exigent d’être recherchées et traitées efficacement sans délai. Rapidement sont recherchées des infections contagieuses à risque épidémique qui nécessitent la mise en place de mesures d’hygiène et de santé publique. L’interrogatoire évalue les caractéristiques de la fièvre, les vaccinations réalisées, les antécédents médico-chirurgicaux et les risques d’exposition aux infections lors du voyage d’après les données géographiques, saisonnières, environnementales, socioculturelles et épidémiologiques. Il oriente avec les données cliniques et paracliniques élémentaires certains examens complémentaires qui permettent un diagnostic étiologique et un traitement optimal dans près de 75 % des cas. La majorité des causes de fièvre des enfants au retour de voyage sont des infections cosmopolites. En cas de paludisme, le traitement antipaludique est une urgence. Cet article décrit la démarche diagnostique et la prise en charge recommandée en France devant un enfant fébrile de retour de voyage.
- Published
- 2016
4. Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria
- Author
-
F. Sorge, E. Marchesini, G. Biolcati, E.I. Minder, Xiaoye Schneider-Yin, and L. Barbieri
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Protoporphyria, Erythropoietic ,Nausea ,Dermatology ,Administration, Cutaneous ,Medication Adherence ,chemistry.chemical_compound ,Quality of life ,Humans ,Medicine ,Adverse effect ,Retrospective Studies ,Melanins ,business.industry ,medicine.disease ,Long-Term Care ,Surgery ,Discontinuation ,Treatment Outcome ,Porphyria ,chemistry ,alpha-MSH ,Delayed-Action Preparations ,Ambulatory ,Quality of Life ,Female ,Afamelanotide ,Dermatologic Agents ,Erythropoietic protoporphyria ,medicine.symptom ,business - Abstract
SummaryBackground In erythropoietic protoporphyria (EPP), an inherited disease of porphyrin-biosynthesis, the accumulation of protoporphyrin in the skin causes severely painful phototoxic reactions. Symptom prevention was impossible until recently when afamelanotide became available. Afamelanotide-induced skin pigmentation has statistically significantly improved light-tolerance, although the clinical significance of the statistical effect was unknown. Objectives To assess clinical effectiveness by recording compliance and safety during prolonged use. Methods We report longitudinal observations of 115 ambulatory patients with EPP, who were treated with a total of 1023 afamelanotide implants over a period of up to 8 years at two porphyria centres; one in Rome, Italy, and the other in Zurich, Switzerland. Results Since the treatment first became available in 2006, the number of patients treated with 16 mg afamelanotide implants rose continuously until June 2014, when 66% of all patients with EPP known to the porphyria centres were treated. Only three patients considered afamelanotide did not meet their expectations for symptom improvement; 23% discontinued the treatment for other, mostly compelling, reasons such as pregnancy or financial restrictions. The quality of life (QoL) scores, measured by an EPP-specific questionnaire, were 31 ± 24% of maximum prior to afamelanotide treatment, rose to 74% after starting afamelanotide and remained at this level during the entire observation period. Only minor adverse events attributable to afamelanotide, predominantly nausea, were recorded. Conclusion Based on the improved QoL scores, high compliance and low discontinuation rates, we conclude that afamelanotide exhibits good clinical effectiveness and good safety in EPP under long-term routine conditions.
- Published
- 2015
- Full Text
- View/download PDF
5. Female genital mutilation: an evaluation of the knowledge of French general and specialized travel medicine practitioners
- Author
-
Mathilde Bourdon, Albert Faye, Adèle Pagès, Barthélémy Lafon-Desmurs, Dora Levy, Camille Aupiais, Claire Tantet, and F. Sorge
- Subjects
Female circumcision ,Male ,medicine.medical_specialty ,Medical knowledge ,Health Knowledge, Attitudes, Practice ,business.industry ,030231 tropical medicine ,General Medicine ,03 medical and health sciences ,0302 clinical medicine ,General Practitioners ,Family medicine ,Surveys and Questionnaires ,Circumcision, Female ,medicine ,Travel medicine ,Humans ,Female ,030212 general & internal medicine ,France ,Prospective Studies ,business ,Travel Medicine - Abstract
We investigated the knowledge of female genital mutilation (FGM) among 60 general and 52 specialized travel medicine practitioners. Less than 50% of these practitioners had adequate knowledge of FGM. Only 42.9% declared having encountered FGM. FGM is likely underestimated in health facilities. Medical education and supporting information should be developed to better address and prevent FGM.
- Published
- 2017
6. What happens to eating disorder outpatients who withdrew from therapy?
- Author
-
G. Di Pietro, C. Bruno, M. Fichele, F. Sorge, L. Valoroso, DI PIETRO, Giancarlo, Valoroso, L, Fichele, M, Bruno, C, and Sorge, Fulvio
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Patient Dropouts ,Treatment outcome ,Anorexia ,dropout ,Body Mass Index ,Feeding and Eating Disorders ,DSM ,Acute onset ,Adaptation, Psychological ,medicine ,Secondary Prevention ,Humans ,Psychiatry ,Secondary prevention ,business.industry ,Eating disorder ,Follow up studies ,Natural history ,Psychiatry and Mental health ,Clinical Psychology ,Treatment Outcome ,Female ,medicine.symptom ,business ,Body mass index ,Attitude to Health ,Follow-Up Studies - Abstract
OBJECTIVE: Dropouts are frequent among eating disorder (ED) patients, but less is known about their natural history. This paper assesses the outcome of outpatients who dropped out from a therapy programme and its possible causes. MATERIAL AND METHODS: From 1992 to 1994, we assessed 222 ED subjects. Psychiatrists expert in EDs evaluated these subjects by defining baseline parameters and diagnosis was made according to the 3rd revisioned edition of the Diagnostic and Statistical Manual of Mental Disorders. One hundred and twenty-eight subjects (57%) dropped out during the treatment. In 1997, we contacted them, reassessed the same baseline parameters and asked for a self-judgment about their social and clinical condition during the previous 2-5 years. Patients were classified as "improved" and "not improved" (stationary or worse) according to their social, physical and psychological condition. The relation between baseline condition and outcome was determined statistically. RESULTS: Seventy-one percent of subjects were "improved" and no deaths were recorded. A significant correlation was found between "duration of illness" and no treatment following a dropout. DISCUSSION: The high percentage of improvement among dropouts was unexpected. Shorter duration of illness and lack of specific therapy in the improved patients suggest the existence of a subset of ED patients with acute onset and a spontaneous tendency to improve. This point obviously requires further investigation.
- Published
- 2003
7. Guidelines and recommendations for the treatment of migraine in paediatric and adolescent patients. Italian Society for the Study of Headache
- Author
-
G, Lanzi, U, Balottin, C A, Zambrino, A, Cernibori, E, Del Bene, V, Gallai, V, Guidetti, and F, Sorge
- Subjects
Adolescent ,Migraine Disorders ,Humans ,Preventive Medicine ,Child - Published
- 1996
8. Probing the non-equilibrium transient state in magnetite by a jitter-free two-color X-ray pump and X-ray probe experiment
- Author
-
N. Pontius, M. Beye, C. Trabant, R. Mitzner, F. Sorgenfrei, T. Kachel, M. Wöstmann, S. Roling, H. Zacharias, R. Ivanov, R. Treusch, M. Buchholz, P. Metcalf, C. Schüßler-Langeheine, and A. Föhlisch
- Subjects
Crystallography ,QD901-999 - Abstract
We present a general experimental concept for jitter-free pump and probe experiments at free electron lasers. By generating pump and probe pulse from one and the same X-ray pulse using an optical split-and-delay unit, we obtain a temporal resolution that is limited only by the X-ray pulse lengths. In a two-color X-ray pump and X-ray probe experiment with sub 70 fs temporal resolution, we selectively probe the response of orbital and charge degree of freedom in the prototypical functional oxide magnetite after photoexcitation. We find electronic order to be quenched on a time scale of (30 ± 30) fs and hence most likely faster than what is to be expected for any lattice dynamics. Our experimental result hints to the formation of a short lived transient state with decoupled electronic and lattice degree of freedom in magnetite. The excitation and relaxation mechanism for X-ray pumping is discussed within a simple model leading to the conclusion that within the first 10 fs the original photoexcitation decays into low-energy electronic excitations comparable to what is achieved by optical pump pulse excitation. Our findings show on which time scales dynamical decoupling of degrees of freedom in functional oxides can be expected and how to probe this selectively with soft X-ray pulses. Results can be expected to provide crucial information for theories for ultrafast behavior of materials and help to develop concepts for novel switching devices.
- Published
- 2018
- Full Text
- View/download PDF
9. Eighth annual meeting of the European Association for the Study of Diabetes
- Author
-
K. G. M. M. Alberti, J. Darley, Pauline M. Emerson, T. D. R. Hockaday, M. Amherdt, A. A. Like, B. Blondel, B. Marliss, C. Wollheim, L. Orci, O. Ortved Andersen, Arne Andersson, F. M. Antonini, C. Fumagalli, E. Petruzzi, G. Bertini, S. Mori, P. Tinti, S. J. H. Ashcroft, L. C. C. Weerasinghe, P. J. Randle, R. Assan, N. Slusher, B. Guy-Grand, F. Girard, E. Soufflet, J. R. Attali, G. Ballerio, J. Boillot, T. Atkins, A. J. Matty, C. J. Bailey, A. Aynsley-Green, S. R. Bloom, R. A. Bacchus, L. G. Meade, D. R. London, L. Balant, G. Zahnd, B. Petitpierre, J. Fabre, E. O. Balasse, M. A. Neef, L. Barta, G. Brooser, Maria Molnar, D. P. Bataille, P. Freychet, P. Kitabgi, G. E. Rosselin, Christian Berne, J. Beyer, U. Cordes, G. Sell, C. Rosak, K. Schöffling, B. Birkner, J. Henner, P. Wagner, F. Erhardt, P. Dieterle, N. J. A. Vaughan, A. V. Edwards, L. Boquist, I. Brand, H. D. Söling, D. Brandenburg, J. Gliemann, H. A. Ooms, W. Puls, A. Wollmer, R. A. Camerini-Davalos, J. M. B. Bloodworth, B. Limburg, W. Oppermann, A. K. Campbell, K. Siddle, J. M. Cañadell, J. Barraquer, A. Muiños, C. D. Heredia, J. Castillo-Olivares, J. Guijo, L. F. Pallardo, E. Cerasi, S. Efendić, R. Luft, J. Wahren, P. Felig, Niels Juel Christensen, A. H. Christiansen, A. Vølund, J. J. Connon, E. Trimble, G. Copinschi, R. Leclercq, O. D. Bruno, E. Haupt, C. Creutzfeldt, N. S. Track, G. S. Cuendet, C. B. Wollheim, D. P. Cameron, W. Stauffacher, E. B. Marliss, A. Czyzyk, B. Lao, W. Bartosiewicz, Z. Szczepanik, E. De Nobel, A. Van't Laar, R. A. P. Koene, Th. J. Benraad, G. Dietze, K. D. Hepp, M. Wickmayr, H. Mehnert, K. Dixon, P. D. Exon, H. R. Hughes, D. W. Jones, R. S. Elkeles, M. G. FitzGerald, J. M. Malins, A. Falorni, F. Massi-Benedetti, G. Gallo, S. Maffei, D. Fedele, A. Tiengo, M. Muggeo, P. Fabris, G. Crepaldi, K. Federlin, K. Helmke, M. Slijepčević, E. F. Pfeiffer, J. P. Felber, J. Oulès, Ch. Schindler, V. Chabot, A. Fernandez-Cruz, E. Catalán, M. Luque Otero, O. Garcia Hermida, J. P. Flatt, G. Blackburn, G. Randers, H. Förster, I Hoos, D. Lerche, I. Hoos, M. Matthäus, J. R. M. Franckson, H. Frerichs, H. Daweke, F. Gries, D. Grüneklee, J. Hessing, K. Jahnke, U. Keup, H. Miss, H. Otto, D. Schmidt, C. Zumfelde, H. v. Funcke, G. Löffler, O. Wieland, D. J. Galton, R. Guttman, G. C. Gazzola, R. Franchi, P. Ronchi, V. Saibene, G. G. Guidotti, V. Gligore, N. Hîncu, Rodica Tecuceanu, R. Goberna, F. Garcia-Albertos, J. Tamarit-Rodriguez, E. del Rio, R. Roca, José Gomez-Acebo, A. V. Creco, G. Fedeli, G. Ghirlanda, R. Fenici, M. Lucente, A. Gutman, G. Agam, N. Nahas, P. Cazalis, E. Gylfe, B. Hellman, D. R. Hadden, J. H. Connolly, D. A. D. Montgomery, J. A. Weaver, Claes Hellerström, Simon Howell, John Edwards, J. Sehlin, I. -B. Täljedal, W. Heptner, H. B. Neubauer, A. Herchuelz, D. G. Pipeleers, W. J. Malaisse, E. Herrera, Eladio Montoya, H. Hommel, IT. Fischer, B. Schmid, H. Fiedler, H. Bibergeil, J. Iversen, P. B. Iynedjian, G. Peters, C. Jacquemin, B. Lambert, B. Ch. J. Sutter, A. Jakob, J. Zapf, E. R. Froesch, F. K. Jansen, G. Freytag, L. Herberg, R. J. Jarrett, I. A. Baker, C. Jarrousse, F. Rancon, D. Job, G. Tchobroutsky, E. Eschwege, C. Guyot-Argenton, J. P. Aubry, M. Déret, H. Karman, P. Mialhe, A. Kissebah, B. Tulloch, Russell Fraser, N. Vydelingum, J. Kissing, S. Raptis, H. Dollinger, J. Faulhaber, G. Rothenbuchner, J. Kleineke, H. Sauer, J. Kloeze, Eva M. Kohner, Barbara A. Sutcliffe, M. Tudball, C. T. Dollery, W. Korp, J. Neubert, H. Bruneder, A. Lenhardt, R. E. Levett, T. Koschinsky, F. A. Gries, M. M. C. Landgraf-Leurs, R. Landgraf, R. Hörl, D. R. Langslow, H. Laube, R. Fussgänger, R. Mayer, H. Klör, E. Lázaro, V. Leclercq-Meyer, J. J. Marchand, W. Malaisse, Thomas Ledet, P. J. Lefébvre, A. S. Luyckx, Y. Le Marchand, F. Assimacopoulos, A. Singh, Ch. Rouiller, B. Jeanrenaud, G. Lenti, R. Frezzotti, G. Angotzi, A. M. Bardelli, G. Pagano, A. Basetti-Sani, M. Galli, Å. Lernmark, G. Fex, D. G. Lindsay, O. Loge, C. Lopez-Quijada, L. Chiva, M. Rodriguez-Lopez, E. G. Loten, A. L. Loubatières, M. M. Loubatières-Mariani, G. Ribes, J. Chapal, J. Lubetzki, J. Duprey, Cl. Sambourg, P. J. Lefebvre, V. Maier, M. Hinz, H. Schatz, C. Nierle, F. Malaisse-Lagae, M. Ravazzola, A. E. Renold, P. Manzano, E. Rojas-Hidalgo, J. Marco, D. Diaz-Fierros, C. Calle, D. Roman, M. L. Villanueva, I. Valverde, A. Like, A. L. Luycks, F. Fracassini, R. Menzel, D. Michaelis, I. Neumann, B. Schulz, W. Wilke, P. Wulfert, K. Krämer, G. Menzinger, F. Fallucca, F. Tamburrano, R. Carratu', D. Andreani, P. Metzger, P. Franken, R. Michael, W. Hildmann, E. Jutzi, J. Michl, S. Fankhauser, J. Schlichtkrull, J. Mirouze, A. Orsetti, Y. Vierne, N. Arnoux, L. Mølsted-Pederson, Inge Tygstrup, Åge L. Villumsen, Jørgen Pedersen, W. Montague, S. L. Howell, A. J. Moody, G. S. Agerbak, F. Sundby, A. Baritussio, Peter Naeser, R. Navalesi, A. Pilo, S. Lenzi, P. Cecchetti, G. Corsini, L. Donato, J. Nerup, G. Bendixen, J. Egeberg, J. E. Poulsen, J. Høiriis Nielsen, F. Mølgaard Hansen, A. Niki, H. Niki, T. Koide, B. J. Lin, R. E. Nikkels, J. Terpstra, A. Gay, R. H. Oakman, Norman R. Lazarus, C. Rouiller, J. Ostman, L. Backman, D. Hallberg, K. Ostrowski, U. Panten, J. Christians, H. -H. Parving, S. Munkgaard Rasmussen, M. Marichal, H. Platilovà, M. Dufek, E. Konopàsek, V. Pozuelo, J. Tamarit, A. Suner, C. Castell, E. D. R. Pruett, S. Maehlum, B. Grebe, M. Chrissiku, R. Müller, H. J. Hinze, H. Reinauer, E. R. Müller-Ruchholtz, X. Rietzler, P. Passa, J. Canivet, J. Otto, G. Behrens, T. Bücher, U. Schlumpf, B. Morell, A. Zingg, J. Schönborn, P. Westphal, G. D. Bloom, L. -A. Idahl, A. Lernmark, M. Söderberg, M. Serrano Rios, F. G. Hawkins, F. Escobar, J. M. Mato, L. Larrodera, M. de Oya, J. L. Rodriguez-Miñon, E. Shafrir, G. Sitbon, Z. Skrabalo, N. Panajatović, Z. Papić, J. Posinovec, A. Stavljenić, V. Lipovac, I. Aganović, N. G. Soler, M. A. Bennett, H. Peters, G. Janson, P. H. Sönksen, M. C. Srivastava, C. V. Tompkins, J. D. N. Nabarro, N. Schwartz Sørensen, K. Ladefoged, K. E. Wildenhoff, F. Sorge, H. -J. Diehl, H. Hoffmann, W. Schwartzkopff, E. Standl, H. Kolb, A. Standl, H. W. Sutherland, J. M. Stowers, J. C. G. Whetham, B. C. J. Sutter, B. Billaudel, M. T. Sutter-Dub, R. Jacquot, I. B. Täljedal, R. Gobema, Gy. Tamás, Éva Baranyi, A. Baranyi, A. Radvanyi, J. Tatoń, A. Hinek, A. Wiśniewska, R. B. Tattersall, D. A. Pyke, J. Bruins Slot, P. L. M. v. d. Sande, J. K. Radder, K. J. J. Waldeok, R. C. P. A. v. Muijden, W. Creutzfeldt, D. S. Turner, R. W. Baker, W. G. L. Gent, A. Shabaan, V. Marks, D. A. B. Young, Ph. Vague, H. Heim, C. Martin Laval, M. Vegezzi, C.Di Campo, G. Rahamandridona, D. Garron, B. Heyraud, J. Vague, I. Lozano, M. Diaz-Fierros, F. A. Van Assche, W. Gepts, E. Van Obberghen, G. Somers, G. Devis, G. D. Vaughan, J. Veleminsky, E. Spirova, W. Waldhäusl, H. Frisch, H. Haydl, L. Weiss, B. Willms, U. Deuticke, M. Zrůstová, and J. Roštlapil
- Subjects
0303 health sciences ,medicine.medical_specialty ,business.industry ,Endocrinology, Diabetes and Metabolism ,Association (object-oriented programming) ,030209 endocrinology & metabolism ,Human physiology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Diabetes mellitus ,Family medicine ,Internal Medicine ,medicine ,business ,030304 developmental biology - Published
- 1973
- Full Text
- View/download PDF
10. [Headaches in the evolutive age: nosographic classification by means of the evaluative rating scale and diagnostic tests]
- Author
-
F, Sorge, L, Steardo, U, Di Furia, C, Florio, G, Di Pietro, and B, Orzalesi
- Subjects
Male ,Migraine Disorders ,Age Factors ,Headache ,Nitroglycerin ,evolutive age ,Child, Preschool ,Surveys and Questionnaires ,headaches ,Female ,Child ,Medical History Taking ,humans ,Bromocriptine ,Histamine - Published
- 1979
11. Source of pain and primitive dysfunction in migraine: an identical site?
- Author
-
Fabrizio Barbieri, E A Ullucci, F Sorge, E Di Stasio, S Bonuso, and E. Marano
- Subjects
Adult ,Male ,Migraine Disorders ,Placebo ,Administration, Cutaneous ,Placebo group ,Temporal lobe ,Double blind study ,Ointments ,Nitroglycerin ,Double-Blind Method ,medicine ,Humans ,Randomized Controlled Trials as Topic ,business.industry ,Middle Aged ,medicine.disease ,Pathophysiology ,Temporal Lobe ,Frontal Lobe ,Psychiatry and Mental health ,Migraine ,Frontal lobe ,One sided ,Anesthesia ,Surgery ,Female ,Neurology (clinical) ,business ,Research Article - Abstract
Twenty common migraine patients received a one sided frontotemporal application of nitroglycerin (10 patients) or placebo ointment (10 patients) in a double blind study. Early onset migraine attacks were induced by nitroglycerin in seven out of 10 patients versus no patient in the placebo group. Subsequently 20 migraine patients, who developed an early onset attack with frontotemporal nitroglycerin, received the drug in a second induction test at other body areas. No early onset migraine was observed. Thus the migraine-inducing effect of nitroglycerin seems to depend on direct stimulation of the habitual site of pain, suggesting that the frontotemporal region is of crucial importance in the development of a migraine crisis. This is not consistent with a CNS origin of migraine attack.
- Published
- 1989
12. Headache in children: a epidemiological study
- Author
-
F, Sorge, U, Giani, L, Steardo, P, Barone, G, Di Pietro, and C, De Lorenzo
- Subjects
Italy ,children ,Humans ,epidemiology ,headache ,Child ,Epidemiologic Methods - Published
- 1981
13. [DPA and clonazepam activity in febrile convulsions: preliminary results]
- Author
-
L, Steardo, C, Florio, F, Sorge, and R, Steardo
- Subjects
Benzodiazepinones ,Clinical Trials as Topic ,Valproic Acid ,Infant ,Receptors, Cell Surface ,clonazepam ,febrile convulsions ,sodium valproate ,Receptors, GABA-A ,Seizures, Febrile ,Seizures ,Child, Preschool ,Humans - Abstract
A pharmacological trial has been performed for the prophylaxis of febrile convulsions in childhood. The administration of two antiepileptic drugs, Sodium Valproate and Clonazepam, reduces significantly seizures occurrence compared with unmedicated controls. Furthermore, Sodium Valproate has been found to be more effective than Clonazepam. Both anticonvulsants are thought to act by a Gabaergic modulation in CNS.
- Published
- 1980
14. Bromocriptine blood-pressure lowering effect in migraine patients. A clinical investigation for a possible mechanism
- Author
-
L, Steardo, E, Marano, and F, Sorge
- Subjects
Adult ,Clinical Trials as Topic ,Adolescent ,Double-Blind Method ,blood-pressure ,Migraine Disorders ,bromocriptine ,migraine ,Humans ,Antihypertensive Agents - Published
- 1979
15. SPIRAMYCIN
- Author
-
E, TURRISI, F, SORGE, and P, POLOSA
- Subjects
Spiramycin - Published
- 1964
16. Vacuum space charge effects in sub-picosecond soft X-ray photoemission on a molecular adsorbate layer
- Author
-
M. Dell'Angela, T. Anniyev, M. Beye, R. Coffee, A. Föhlisch, J. Gladh, S. Kaya, T. Katayama, O. Krupin, A. Nilsson, D. Nordlund, W. F. Schlotter, J. A. Sellberg, F. Sorgenfrei, J. J. Turner, H. Öström, H. Ogasawara, M. Wolf, and W. Wurth
- Subjects
Crystallography ,QD901-999 - Abstract
Vacuum space charge induced kinetic energy shifts of O 1s and Ru 3d core levels in femtosecond soft X-ray photoemission spectra (PES) have been studied at a free electron laser (FEL) for an oxygen layer on Ru(0001). We fully reproduced the measurements by simulating the in-vacuum expansion of the photoelectrons and demonstrate the space charge contribution of the high-order harmonics in the FEL beam. Employing the same analysis for 400 nm pump-X-ray probe PES, we can disentangle the delay dependent Ru 3d energy shifts into effects induced by space charge and by lattice heating from the femtosecond pump pulse.
- Published
- 2015
- Full Text
- View/download PDF
17. Development of experimental techniques for the characterization of ultrashort photon pulses of extreme ultraviolet free-electron lasers
- Author
-
S. Düsterer, M. Rehders, A. Al-Shemmary, C. Behrens, G. Brenner, O. Brovko, M. DellAngela, M. Drescher, B. Faatz, J. Feldhaus, U. Frühling, N. Gerasimova, N. Gerken, C. Gerth, T. Golz, A. Grebentsov, E. Hass, K. Honkavaara, V. Kocharian, M. Kurka, Th. Limberg, R. Mitzner, R. Moshammer, E. Plönjes, M. Richter, J. Rönsch-Schulenburg, A. Rudenko, H. Schlarb, B. Schmidt, A. Senftleben, E. A. Schneidmiller, B. Siemer, F. Sorgenfrei, A. A. Sorokin, N. Stojanovic, K. Tiedtke, R. Treusch, M. Vogt, M. Wieland, W. Wurth, S. Wesch, M. Yan, M. V. Yurkov, H. Zacharias, and S. Schreiber
- Subjects
Nuclear and particle physics. Atomic energy. Radioactivity ,QC770-798 - Abstract
One of the most challenging tasks for extreme ultraviolet, soft and hard x-ray free-electron laser photon diagnostics is the precise determination of the photon pulse duration, which is typically in the sub 100 fs range. Nine different methods, able to determine such ultrashort photon pulse durations, were compared experimentally at FLASH, the self-amplified spontaneous emission free-electron laser at DESY in Hamburg, in order to identify advantages and disadvantages of different methods. Radiation pulses at a wavelength of 13.5 and 24.0 nm together with the corresponding electron bunch duration were measured by indirect methods like analyzing spectral correlations, statistical fluctuations, and energy modulations of the electron bunch and also by direct methods like autocorrelation techniques, terahertz streaking, or reflectivity changes of solid state samples. In this paper, we present a comprehensive overview of the various techniques and a comparison of the individual experimental results. The information gained is of utmost importance for the future development of reliable pulse duration monitors indispensable for successful experiments with ultrashort extreme ultraviolet pulses.
- Published
- 2014
- Full Text
- View/download PDF
18. Comparative analysis of bones, mites, soil chemistry, nematodes and soil micro-eukaryotes from a suspected homicide to estimate the post-mortem interval.
- Author
-
Szelecz I, Lösch S, Seppey CVW, Lara E, Singer D, Sorge F, Tschui J, Perotti MA, and Mitchell EAD
- Subjects
- Adolescent, Adult, Animals, Humans, Postmortem Changes, Young Adult, Bone and Bones chemistry, Homicide, Mites, Nematoda, Soil chemistry, Soil Microbiology
- Abstract
Criminal investigations of suspected murder cases require estimating the post-mortem interval (PMI, or time after death) which is challenging for long PMIs. Here we present the case of human remains found in a Swiss forest. We have used a multidisciplinary approach involving the analysis of bones and soil samples collected beneath the remains of the head, upper and lower body and "control" samples taken a few meters away. We analysed soil chemical characteristics, mites and nematodes (by microscopy) and micro-eukaryotes (by Illumina high throughput sequencing). The PMI estimate on hair
14 C-data via bomb peak radiocarbon dating gave a time range of 1 to 3 years before the discovery of the remains. Cluster analyses for soil chemical constituents, nematodes, mites and micro-eukaryotes revealed two clusters 1) head and upper body and 2) lower body and controls. From mite evidence, we conclude that the body was probably brought to the site after death. However, chemical analyses, nematode community analyses and the analyses of micro-eukaryotes indicate that decomposition took place at least partly on site. This study illustrates the usefulness of combining several lines of evidence for the study of homicide cases to better calibrate PMI inference tools.- Published
- 2018
- Full Text
- View/download PDF
19. Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.
- Author
-
Nemethova M, Radvanszky J, Kadasi L, Ascher DB, Pires DE, Blundell TL, Porfirio B, Mannoni A, Santucci A, Milucci L, Sestini S, Biolcati G, Sorge F, Aurizi C, Aquaron R, Alsbou M, Lourenço CM, Ramadevi K, Ranganath LR, Gallagher JA, van Kan C, Hall AK, Olsson B, Sireau N, Ayoob H, Timmis OG, Sang KH, Genovese F, Imrich R, Rovensky J, Srinivasaraghavan R, Bharadwaj SK, Spiegel R, and Zatkova A
- Subjects
- Alkaptonuria diagnosis, Alkaptonuria enzymology, Alkaptonuria pathology, Base Sequence, Bone Diseases, Metabolic diagnosis, Bone Diseases, Metabolic enzymology, Bone Diseases, Metabolic pathology, Bone and Bones pathology, Catalytic Domain, Databases, Genetic, Exons, Female, Gene Expression, Genetic Heterogeneity, Homogentisate 1,2-Dioxygenase chemistry, Humans, Introns, Italy, Male, Models, Molecular, Molecular Sequence Data, Pedigree, Phenotype, Protein Structure, Secondary, Sequence Analysis, DNA, Alkaptonuria genetics, Bone Diseases, Metabolic genetics, Bone and Bones enzymology, Homogentisate 1,2-Dioxygenase genetics, Mutation, Missense, Polymorphism, Single Nucleotide
- Abstract
Alkaptonuria (AKU) is an autosomal recessive disorder caused by mutations in homogentisate-1,2-dioxygenase (HGD) gene leading to the deficiency of HGD enzyme activity. The DevelopAKUre project is underway to test nitisinone as a specific treatment to counteract this derangement of the phenylalanine-tyrosine catabolic pathway. We analysed DNA of 40 AKU patients enrolled for SONIA1, the first study in DevelopAKUre, and of 59 other AKU patients sent to our laboratory for molecular diagnostics. We identified 12 novel DNA variants: one was identified in patients from Brazil (c.557T>A), Slovakia (c.500C>T) and France (c.440T>C), three in patients from India (c.469+6T>C, c.650-85A>G, c.158G>A), and six in patients from Italy (c.742A>G, c.614G>A, c.1057A>C, c.752G>A, c.119A>C, c.926G>T). Thus, the total number of potential AKU-causing variants found in 380 patients reported in the HGD mutation database is now 129. Using mCSM and DUET, computational approaches based on the protein 3D structure, the novel missense variants are predicted to affect the activity of the enzyme by three mechanisms: decrease of stability of individual protomers, disruption of protomer-protomer interactions or modification of residues in the region of the active site. We also present an overview of AKU in Italy, where so far about 60 AKU cases are known and DNA analysis has been reported for 34 of them. In this rather small group, 26 different HGD variants affecting function were described, indicating rather high heterogeneity. Twelve of these variants seem to be specific for Italy.
- Published
- 2016
- Full Text
- View/download PDF
20. EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury.
- Author
-
Nührenberg TG, Langwieser N, Schwarz JB, Hou Y, Frank P, Sorge F, Matschurat S, Seidl S, Kastrati A, Schömig A, Clauss MA, and Zohlnhöfer D
- Subjects
- Angioplasty, Balloon, Coronary, Animals, Apoptosis, Cells, Cultured, Coronary Restenosis prevention & control, Coronary Vessels pathology, Down-Regulation, Inflammation etiology, Macrophages physiology, Mice, Sirolimus antagonists & inhibitors, Cytokines physiology, Neoplasm Proteins physiology, RNA-Binding Proteins physiology, Sirolimus pharmacology, Tunica Intima pathology
- Abstract
Aims: Neointima formation after vascular injury is strongly associated with inflammation. Rapamycin inhibits human neointima formation and reduces expression of the proinflammatory cytokine endothelial-monocyte activating peptide II (EMAP-II) in vitro. Here we investigated the interplay between EMAP-II and rapamycin after vascular injury in vivo., Methods and Results: In a mouse model of vascular injury, mice were either not treated, given everolimus, a rapamycin derivate, or subjected to simultaneous challenge with everolimus and EMAP-II. EMAP-II expression was measured in coronary artery smooth muscle cells (CASMC) and monocytic cells in vitro and in patients after percutaneous coronary intervention (PCI). After vascular injury, rapamycin reduced neointima formation and adventitial thickening. Immunohistochemistry revealed reduced EMAP-II protein expression and suppressed recruitment of inflammatory cells. Simultaneous challenge with EMAP-II counteracted these effects of rapamycin. Expression of EMAP-II and its inhibition by rapamycin was confirmed in CASMC and monocytic cells. In patients, EMAP-II upregulation was confined to PCI of distal coronary artery segments and profoundly suppressed by oral rapamycin treatment., Conclusion: These data suggest important yet unrecognized roles of EMAP-II and adventitial inflammation in neointima formation: Through inhibition of EMAP-II, rapamycin reduces the recruitment of inflammatory cells to the adventitia and supports an early and bland healing.
- Published
- 2008
- Full Text
- View/download PDF
21. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo.
- Author
-
Massberg S, Konrad I, Schürzinger K, Lorenz M, Schneider S, Zohlnhoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, Schulz C, Kerstan S, Rudelius M, Seidl S, Sorge F, Langer H, Peluso M, Goyal P, Vestweber D, Emambokus NR, Busch DH, Frampton J, and Gawaz M
- Subjects
- Animals, Antigens, Differentiation metabolism, Arteries injuries, Arteries metabolism, Arteries pathology, Blood Platelets pathology, Bone Marrow Cells pathology, Cell Adhesion, Chemokine CXCL12, Endothelium, Vascular metabolism, Endothelium, Vascular pathology, Mice, Microscopy, Fluorescence, Myocytes, Smooth Muscle metabolism, Myocytes, Smooth Muscle pathology, Platelet Activation, Recovery of Function, Stem Cells pathology, Thrombosis pathology, Blood Platelets metabolism, Bone Marrow Cells metabolism, Cell Movement, Chemokines, CXC metabolism, Stem Cells metabolism, Thrombosis metabolism
- Abstract
The accumulation of smooth muscle and endothelial cells is essential for remodeling and repair of injured blood vessel walls. Bone marrow-derived progenitor cells have been implicated in vascular repair and remodeling; however, the mechanisms underlying their recruitment to the site of injury remain elusive. Here, using real-time in vivo fluorescence microscopy, we show that platelets provide the critical signal that recruits CD34+ bone marrow cells and c-Kit+ Sca-1+ Lin- bone marrow-derived progenitor cells to sites of vascular injury. Correspondingly, specific inhibition of platelet adhesion virtually abrogated the accumulation of both CD34+ and c-Kit+ Sca-1+ Lin- bone marrow-derived progenitor cells at sites of endothelial disruption. Binding of bone marrow cells to platelets involves both P-selectin and GPIIb integrin on platelets. Unexpectedly, we found that activated platelets secrete the chemokine SDF-1alpha, thereby supporting further primary adhesion and migration of progenitor cells. These findings establish the platelet as a major player in the initiation of vascular remodeling, a process of fundamental importance for vascular repair and pathological remodeling after vascular injury.
- Published
- 2006
- Full Text
- View/download PDF
22. What happens to eating disorder outpatients who withdrew from therapy?
- Author
-
Di Pietro G, Valoroso L, Fichele M, Bruno C, and Sorge F
- Subjects
- Adaptation, Psychological, Adult, Attitude to Health, Body Mass Index, Feeding and Eating Disorders diagnosis, Feeding and Eating Disorders psychology, Female, Follow-Up Studies, Humans, Male, Secondary Prevention, Treatment Outcome, Feeding and Eating Disorders therapy, Patient Dropouts psychology
- Abstract
Objective: Dropouts are frequent among eating disorder (ED) patients, but less is known about their natural history. This paper assesses the outcome of outpatients who dropped out from a therapy programme and its possible causes., Material and Methods: From 1992 to 1994, we assessed 222 ED subjects. Psychiatrists expert in EDs evaluated these subjects by defining baseline parameters and diagnosis was made according to the 3rd revisioned edition of the Diagnostic and Statistical Manual of Mental Disorders. One hundred and twenty-eight subjects (57%) dropped out during the treatment. In 1997, we contacted them, reassessed the same baseline parameters and asked for a self-judgment about their social and clinical condition during the previous 2-5 years. Patients were classified as "improved" and "not improved" (stationary or worse) according to their social, physical and psychological condition. The relation between baseline condition and outcome was determined statistically., Results: Seventy-one percent of subjects were "improved" and no deaths were recorded. A significant correlation was found between "duration of illness" and no treatment following a dropout., Discussion: The high percentage of improvement among dropouts was unexpected. Shorter duration of illness and lack of specific therapy in the improved patients suggest the existence of a subset of ED patients with acute onset and a spontaneous tendency to improve. This point obviously requires further investigation.
- Published
- 2002
- Full Text
- View/download PDF
23. Source of pain and primitive dysfunction in migraine: an identical site?
- Author
-
Bonuso S, Marano E, di Stasio E, Sorge F, Barbieri F, and Ullucci EA
- Subjects
- Administration, Cutaneous, Adult, Double-Blind Method, Female, Frontal Lobe drug effects, Humans, Male, Middle Aged, Nitroglycerin adverse effects, Ointments, Randomized Controlled Trials as Topic, Temporal Lobe drug effects, Migraine Disorders chemically induced, Nitroglycerin administration & dosage
- Abstract
Twenty common migraine patients received a one sided frontotemporal application of nitroglycerin (10 patients) or placebo ointment (10 patients) in a double blind study. Early onset migraine attacks were induced by nitroglycerin in seven out of 10 patients versus no patient in the placebo group. Subsequently 20 migraine patients, who developed an early onset attack with frontotemporal nitroglycerin, received the drug in a second induction test at other body areas. No early onset migraine was observed. Thus the migraine-inducing effect of nitroglycerin seems to depend on direct stimulation of the habitual site of pain, suggesting that the frontotemporal region is of crucial importance in the development of a migraine crisis. This is not consistent with a CNS origin of migraine attack.
- Published
- 1989
- Full Text
- View/download PDF
24. SPIRAMYCIN.
- Author
-
TURRISI E, SORGE F, and POLOSA P
- Subjects
- Spiramycin
- Published
- 1964
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.